Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment.
Clinical trial NCT03066427 · COMPLETED
Trial details
- NCT number
- NCT03066427
- Sponsor
- Spanish Oncology Genito-Urinary Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-10
- Primary completion
- 2020-09-22
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.